India · Delayed Price · Currency is INR Sai Life Sciences Statistics
Total Valuation
BOM:544306 has a market cap or net worth of INR 309.14 billion. The enterprise value is 310.44 billion.
| Market Cap | 309.14B |
| Enterprise Value | 310.44B |
Important Dates
The last earnings date was Thursday, August 6, 2026.
| Earnings Date | Aug 6, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 212.12M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +3.47% |
| Shares Change (QoQ) | +0.12% |
| Owned by Insiders (%) | 13.61% |
| Owned by Institutions (%) | 43.70% |
| Float | 93.98M |
Valuation Ratios
The trailing PE ratio is 85.46 and the forward PE ratio is 69.30.
| PE Ratio | 85.46 |
| Forward PE | 69.30 |
| PS Ratio | 13.74 |
| PB Ratio | 12.45 |
| P/TBV Ratio | 12.48 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 60.72 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 85.82 |
| EV / Sales | 13.80 |
| EV / EBITDA | 46.37 |
| EV / EBIT | 64.25 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.12 |
| Debt / EBITDA | 0.43 |
| Debt / FCF | -3.44 |
| Interest Coverage | 14.00 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 13.83% |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 6.62M |
| Profits Per Employee | 1.06M |
| Employee Count | 3,401 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, BOM:544306 has paid 1.22 billion in taxes.
| Income Tax | 1.22B |
| Effective Tax Rate | 25.17% |
Stock Price Statistics
The stock price has increased by +59.96% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +59.96% |
| 50-Day Moving Average | 1,300.26 |
| 200-Day Moving Average | 1,048.85 |
| Relative Strength Index (RSI) | 63.76 |
| Average Volume (20 Days) | 45,537 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BOM:544306 had revenue of INR 22.50 billion and earned 3.62 billion in profits. Earnings per share was 17.02.
| Revenue | 22.50B |
| Gross Profit | 16.76B |
| Operating Income | 4.83B |
| Pretax Income | 4.83B |
| Net Income | 3.62B |
| EBITDA | 6.69B |
| EBIT | 4.83B |
| Earnings Per Share (EPS) | 17.02 |
Balance Sheet
The company has 1.58 billion in cash and 2.88 billion in debt, with a net cash position of -1.31 billion.
| Cash & Cash Equivalents | 1.58B |
| Total Debt | 2.88B |
| Net Cash | -1.31B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 24.84B |
| Book Value Per Share | 117.47 |
| Working Capital | n/a |
Cash Flow
In the last 12 months, operating cash flow was 5.09 billion and capital expenditures -5.93 billion, giving a free cash flow of -838.28 million.
| Operating Cash Flow | 5.09B |
| Capital Expenditures | -5.93B |
| Depreciation & Amortization | 1.86B |
| Net Borrowing | -949.38M |
| Free Cash Flow | -838.28M |
| FCF Per Share | n/a |
Margins
Gross margin is 74.46%, with operating and profit margins of 21.47% and 16.07%.
| Gross Margin | 74.46% |
| Operating Margin | 21.47% |
| Pretax Margin | 21.48% |
| Profit Margin | 16.07% |
| EBITDA Margin | 29.75% |
| EBIT Margin | 21.47% |
| FCF Margin | n/a |
Dividends & Yields
BOM:544306 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -3.47% |
| Shareholder Yield | -3.47% |
| Earnings Yield | 1.17% |
| FCF Yield | -0.27% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for BOM:544306 is 1,552.67, which is 6.61% higher than the current price. The consensus rating is "Buy".
| Price Target | 1,552.67 |
| Price Target Difference | 6.61% |
| Analyst Consensus | Buy |
| Analyst Count | 7 |
| Revenue Growth Forecast (3Y) | 21.13% |
| EPS Growth Forecast (3Y) | 24.15% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 4 |